SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950115-00-000683
Filing Date
2000-05-12
Accepted
2000-05-12 00:00:00
Documents
7

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A SC 13D/A 34690
2 JOINT FILING AGREEMENT EX-1 2943
3 STOCK PURCHASE AGREEMENT EX-2 153110
4 STOCK PURCHASE AGREEMENT EX-3 153130
5 REGISTRATION RIGHTS AGREEMENT EX-5 75068
6 AMENDMENT NO. 1 TO STOCKHOLDERS' AGREEMENT EX-6 10075
7 AMENDMENT TO RESTATED REGISTRATION RIGHTS AGREE. EX-7 7892
  Complete submission text file 0000950115-00-000683.txt   439716
Mailing Address 320 PARK AVE 11TH AND 12TH FL NEW YORK NY 10022
Business Address 320 PARK AVENUE 11TH & 12TH FL NEW YORK NY 10022 2125083600
FLEMING ROBERT INC / DA (Filed by) CIK: 0000902812 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 0331
SIC: 0000

Mailing Address CASTOR & KENSINGTON AVENUES PHILADELPHIA PA 19124-5694
Business Address CASTOR & KENSINGTON AVES PHILADELPHIA PA 19124-5694 2152892220
IMPAX LABORATORIES INC (Subject) CIK: 0001003642 (see all company filings)

IRS No.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-48867 | Film No.: 628526
SIC: 2834 Pharmaceutical Preparations